WLSI.OB Wellstar International Inc. Stock Medical Appliances & Equipment

[greencat]

Wellstar/TMI Announces Estimated Three-Year Revenue Projections
Wednesday, January 07 2009 - 16:23

WLSI $0.0028 $0.0008 (%40)

HOLLAND, OH -- (MARKET WIRE) -- 01/07/09 --
Wellstar International, Inc. (OTCBB: WLSI), a
provider of specialized diagnostic software and equipment, announced today
its updated revenue projection guidance for fiscal years 2009 through 2011,
based on the leasing of its thermal imaging system to long-term care
("LTC") facilities. Wellstar International announced two days ago that the
revolutionary imaging system developed by the Company''s TMI subsidiary,
which can be used for the early detection of pressure ulcers, is now being
marketed to the vast LTC market in the U.S. via a special leasing program.
This lease program makes these systems now more affordable and essentially
a "must-have" for long-term care facilities seeking to curtail potential
liabilities and receive a higher rating from CMS under the agency''s "pay
for performance" standards.





Wellstar/TMI estimates revenues for its fiscal year 2009 will be in excess
of $16 million, for 2010, they should be in excess of $69 million, and
revenues are projected to be $133 million in 2011. The Company also
anticipates that it will be cash flow positive in fiscal year 2009.





The Company''s wholly-owned subsidiary, Trillennium Medical Imaging ("TMI"),
has begun marketing its thermal imaging system to the approximately 16,000
LTC facilities throughout the United States, and it anticipates installing
devices as early as April-2009. The Company has initiated a marketing plan
that calls for the installation of 300 FDA approved thermal imaging systems
per month through 2010, increasing that number to 400 per month by 2011.





Wellstar/TMI CEO, John Antonio, commented, "We believe that the Company is
in a strong position to capitalize on this technology via the leasing
program we have implemented. These revenues projected are based on only one
intended application of this revolutionary thermal imaging system. We fully
expect to market our systems for other applications in the near future. I
hope that these revenue projections will now give investors a much clearer
picture of our emerging business."


<


BR>

ABOUT WELLSTAR INTERNATIONAL, INC.:





Wellstar International, Inc., through its wholly owned operating subsidiary
Trillennium Medical Imaging, Inc. (TMI), is poised to become a leading
diagnostic company in the health care industry. TMI has developed and is
marketing fully calibrated and functional, thermal imaging systems that
utilize state-of-the-art infrared technologies and proprietary software to
accurately and cost-effectively measure physiological changes in the human
body. More information on the Company and its unique diagnostic software
and product line is available on Wellstar''s corporate Website, by visiting:
Untitled Document.





FORWARD-LOOKING STATEMENTS:





This press release contains statements, which may constitute
''forward-looking statements'' within the meaning of the Securities Act of
1933 and the Securities Exchange Act of 1934, as amended by the Private
Securities Litigation Reform Act of 1995. Prospective investors are
cautioned that any such forward-looking statements are not guarantees of
future performance and involve risks and uncertainties, and that actual
results may differ materially from those contemplated by such
forward-looking statements. Important factors currently known to management
that could cause actual results to differ materially from those in
forward-statements include fluctuation of operating results, the ability to
compete successfully and the ability to complete before-mentioned
transactions. The company undertakes no obligation to update or revise
forward-looking statements to reflect changed assumptions, the occurrence
of unanticipated events or changes to future operating results.





CONTACT:Equiti-trend Advisors LLC(800) 953-3350 Toll-Free, U.S. & Canada(858) 436-3350 Local or International9:30 a.m. to 5:00 p.m. Daily


Shares Outstanding5: 534.92M
Float: 398.49M

FINANCIAL HIGHLIGHTS

Fiscal Year
Fiscal Year Ends: 31-July
Most Recent Quarter (mrq): 31-Oct-08


Profitability
Profit Margin (ttm): N/A
Operating Margin (ttm): N/A


Management Effectiveness
Return on Assets (ttm): -135.91%
Return on Equity (ttm): N/A


Income Statement
Revenue (ttm): N/A
Revenue Per Share (ttm): N/A
Qtrly Revenue Growth (yoy): N/A
Gross Profit (ttm): N/A
EBITDA (ttm): -2.06M
Net Income Avl to Common (ttm): -1.60M
Diluted EPS (ttm): -0.005
Qtrly Earnings Growth (yoy): N/A


Balance Sheet
Total Cash (mrq): 113
Total Cash Per Share (mrq): 0
Total Debt (mrq): 1.85M
Total Debt/Equity (mrq): N/A
Current Ratio (mrq): 0.024
Book Value Per Share (mrq): -0.02


Cash Flow Statement
Operating Cash Flow (ttm): -921.23K
Levered Free Cash Flow (ttm): 2.15M

[nitrostockz]

Hello there everyone: I would like to present this stock to this board. As many of you know me from other boards I found StockMarketCats and thought I would give a pick here that I think could blow the pants off my other picks.

WLSI is currently sitting at about .002 which is right near it's low end base. Current levels in my opinion represent an excellent opportunity to get positioned into this stock giving possible upside potential.

The Company:

Wellstar International, Inc., through its wholly owned operating subsidiary Trillenium Medical Imaging, Inc. (TMI), is poised to become a leading diagnostic company in the health care industry. TMI has developed and is marketing fully calibrated and functional, thermal imaging systems that utilize state-ofthe-art infrared technologies and proprietary software to accurately and cost-effectively measure physiological changes in humans, in a hospital setting.

Infrared thermal imaging is a non-invasive, imaging procedure involving the detection and recording of skin thermal patterns, providing visual and quantitative documentation. The interpretation of these temperatures and thermal patterns can play an important part in the development of a diagnosis. Because Infrared Imaging can display the variations in skin temperature patterns and these variations are known pathways of information, it can be invaluable as an integral part of the physical examination.

Such technology has been successfully tested and is currently in use to assist in diagnosis, treatment monitoring and case management of many health issues. These include, but not limited to: vascular, neurological and muscular-skeletal disorders such as breast cancer, diabetes, and unresolved pain issues related to myofascial complaints, muscle injury or neurological dysfunction.


Website: Untitled Document

At current prices this company could be an ideal situation for investors looking for above average returns with minimal downside risk.

[nitrostockz]

Impressive Revenue Projections:

Wellstar/TMI Announces Estimated Three-Year Revenue Projections
Wednesday January 7, 4:22 pm ET


HOLLAND, OH--(MARKET WIRE)--Jan 7, 2009 -- Wellstar International, Inc. (OTC BB:WLSI.OB - News), a provider of specialized diagnostic software and equipment, announced today its updated revenue projection guidance for fiscal years 2009 through 2011, based on the leasing of its thermal imaging system to long-term care ("LTC") facilities. Wellstar International announced two days ago that the revolutionary imaging system developed by the Company's TMI subsidiary, which can be used for the early detection of pressure ulcers, is now being marketed to the vast LTC market in the U.S. via a special leasing program. This lease program makes these systems now more affordable and essentially a "must-have" for long-term care facilities seeking to curtail potential liabilities and receive a higher rating from CMS under the agency's "pay for performance" standards.
ADVERTISEMENT


Wellstar/TMI estimates revenues for its fiscal year 2009 will be in excess of $16 million, for 2010, they should be in excess of $69 million, and revenues are projected to be $133 million in 2011. The Company also anticipates that it will be cash flow positive in fiscal year 2009.

The Company's wholly-owned subsidiary, Trillennium Medical Imaging ("TMI"), has begun marketing its thermal imaging system to the approximately 16,000 LTC facilities throughout the United States, and it anticipates installing devices as early as April-2009. The Company has initiated a marketing plan that calls for the installation of 300 FDA approved thermal imaging systems per month through 2010, increasing that number to 400 per month by 2011.

Wellstar/TMI CEO, John Antonio, commented, "We believe that the Company is in a strong position to capitalize on this technology via the leasing program we have implemented. These revenues projected are based on only one intended application of this revolutionary thermal imaging system. We fully expect to market our systems for other applications in the near future. I hope that these revenue projections will now give investors a much clearer picture of our emerging business."

[nitrostockz]

Wellstar/TMI Joins Fight Against Bedsores Epidemic


HOLLAND, OH--(MARKET WIRE)--Jan 12, 2009 -- Wellstar International, Inc. (OTC BB:WLSI.OB - News), a provider of specialized diagnostic software and equipment, announced today that its wholly owned subsidiary, Trillennium Medical Imaging ("TMI"), has now joined the fight to quell a growing epidemic among patients in the U.S. that are bed-ridden. Pressure ulcers or decubitus ulcers, commonly known as bedsores, affect hundreds of thousands of patients admitted to healthcare facilities and/or long-term care facilities in the U.S. every year.

The Company's revolutionary thermal imaging system allows nursing staff to objectively identify patterns of injury associated with the development of pressure ulcers, which can lead to an intervention and even prevention of bedsores. According to a recent government report, the number of hospital patients with bedsores has risen dramatically over a 14-year period, leading to longer, more expensive hospital stays. By identifying the tissue changes associated with the development of these wounds prior to skin breakdown, the patient can avoid bedsore occurrences altogether, therefore receiving better care from the nursing staff at these facilities.

Wellstar/TMI CEO John Antonio stated, "We are ready to take this serious epidemic head on. Our team has been aggressively reaching out to educate the caregivers at these facilities regarding our thermal imaging system technology. This is a problem that can be eventually eliminated."

For more information on pressure ulcers, please visit: National Pressure Ulcer Advisory Panel (NPUAP) and Bed Sores - Information and Resources

Based on the existing market for TMI's diagnostic system, Wellstar is anticipating revenues in the current year to exceed $16 million.

[nitrostockz]

This is the latest PR from WLSI - I would expect more news soon as the company starts to ramp up their sales and gets closer to announcing results from studies in the other areas they are focused on.

Wellstar/TMI Announces Pending Pressure Ulcer Study on Leg and Foot Ulcers
Wednesday January 14, 5:03 pm ET


HOLLAND, OH--(MARKET WIRE)--Jan 14, 2009 -- Wellstar International, Inc. (OTC BB:WLSI.OB - News), a provider of specialized diagnostic software and equipment, announced today that its wholly owned subsidiary, Trillennium Medical Imaging ("TMI"), has begun negotiations for a pressure ulcer study focused on ulcers caused by diabetic foot and venous legs. The Company is currently in talks with several major teaching and research universities, the goal of which is to secure a clinical partner for this study. Wellstar anticipates that the study could start as early as March 2009.

In the U.S. alone, approximately 1.5 million adults are treated each year for pressure ulcers (bedsores) with associated health care costs of over $5 billion. Regrettably, more than 65,000 patients die each year from complications related to these ulcers. Pressure ulcers represent one of four of the most common and costly deficiencies found in long-term care facilities.

A diabetic foot ulcer is a sore or wound that often occurs in people with diabetes; these ulcers may be difficult to heal, susceptible to infection and may lead to amputation of the affected toe, foot or leg if not treated. Over 850,000 chronic diabetic ulcers are diagnosed in the U.S. each year. Approximately 3 million diabetic patients will develop an ulcer and 25% of these patients will have a foot amputated.

Venous leg ulcer is a sore or wound that is caused by poor circulation of blood in the veins of the legs usually caused by faulty valves allowing pressure to build up in the veins. This pressure causes damage to the tiny blood vessels in the skin, making the skin become thin and inflamed, and causing the death of tissue cells leading to the ulcer.

The Company's infrared imaging system involves the detection and recording of skin temperature and injury patterns, providing visual and quantitative documentation to accurately capture body temperature data. The Company's system map changes in skin blood flow by translating temperature data into pictures. The interpretation of these temperatures and thermal patterns can play an important role in detecting these sores at an early stage.

Wellstar/TMI CEO John Antonio stated, "We are looking forward to working with one of the clinical partners that we are currently communicating with about this planned study. Early detection of pressure ulcers is critical and can actually help prevent ulcer outbreaks among patients. The TMI infrared imaging system is a viable tool, and should soon prove to be the medical standard for predicting and preventing pressure ulcers in the medical community. "

[nitrostockz]

Look for entry here around the .002 to .0025 range. If this climbs above the .0025 range look for a breakout to the .0035. Movement past the .0035 range signals a strong breakout to the upside. Any way you slice it, this has little downside and upside potential.

Let's just see how the next few weeks play out.

I will give a couple more picks to the board in the next week or so for review and we can see how they do as well. All discussions appreciated.

~Nitro

[nitrostockz]

Now this is a nice entry price: .0016 X .0018 currently.

[nitrostockz]

Congrats to those that picked this up today. It closed up at .002 on over 11 million shares traded. Watch this closely in the coming days for a decent breakout to the upside.

[nitrostockz]

No selling pressure to speak of on this one. It had a very quiet day today with all trades on the ask. The quiet trading and solid bid support could mean that a breakout to the upside is imminent.

Keep this on your watch list.

[Swift4Profit]

I knew I should've pulled the trigger at .0015, oh well.